Lyrica Dose Response Study With Restless Legs Syndrome (RLS) Patients

Clinical trial NCT00676403 · COMPLETED

Trial details

NCT number: NCT00676403
Sponsor: Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Restless Legs Syndrome

Start date: 2008-04-01
Primary completion: 2009-01-01
Enrollment: 137

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.